Glenmark Pharmaceuticals Ltd.
ShareGLENMARK Competitor Analysis
| GLENMARK | SUNPHARMA  | DIVISLAB | TORNTPHARM | CIPLA | |
|---|---|---|---|---|---|
Overview | |||||
| Current price (₹) As on 21 Nov, 2025, 02:09 PM | 1,866.10 0% | 1,784.50 0% | 6,412.50 0% | 3,699.10 0% | 1,522.50 0% |
| Market cap (₹ Cr) | 52,661 | 4,28,161 | 1,70,232 | 1,25,194 | 1,22,981 |
Past ReturnsAbsolute Returns Shown | |||||
| 1D | -1.4% | -0.29% | -0.69% | -0.75% | -1.37% |
| 1W | -0.27% | 1.54% | -0.71% | -0.88% | -0.32% |
| 1M | -0.54% | 4.16% | -1.98% | 6.17% | -7.6% |
| 3M | -4.22% | 7.7% | 7.8% | 3.47% | -2.04% |
| 6M | 28.31% | 2.99% | 0.33% | 16.95% | 4.13% |
| 1Y | 23.46% | -1.04% | 9.7% | 22.49% | 2.92% |
| 5Y | 282.44% | 249.49% | 86.6% | 190.49% | 104.69% |
Income StatementAnnual data as on 13 Dec 2025. All values in ₹ Cr. YoY growth displayed | |||||
| Sales | 9,226 16.92% | 52,578 8.41% | 9,360 19.31% | 11,516 7.35% | 27,548 6.88% |
| OPM (%) | 23.42 70.82% | 28 7.2% | 30.56 13.44% | 32.25 3.3% | 25.09 5.78% |
| PBT | 2,154 -69.23% | 13,752 24.03% | 2,916 34.81% | 2,673 13.65% | 6,821 19.62% |
PAT | 1,610 -68.84% | 10,980 13.81% | 2,191 36.94% | 1,911 15.4% | 5,291 27.34% |
| Net Profit Margin | 17.45 -73.35% | 20.85 5.2% | 23.41 14.75% | 16.6 7.51% | 19.13 18.67% |
| EPS | 57.07 -68.84% | 45.55 14.13% | 82.53 36.93% | 56.47 15.39% | 65.28 27.87% |
Balance Sheet & Cash FlowAnnual data as on 13 Dec 2025. All values in ₹ Cr. YoY growth displayed | |||||
| Net Worth | 24,504 6.69% | 72,218 13.43% | 14,969 10.3% | 7,591 10.72% | 31,193 16.8% |
| Total Assets | 28,033 2.26% | 92,101 7.77% | 16,932 9.45% | 14,990 -0.47% | 37,387 14.27% |
| Total Outside Liabilities | 3,529 -20.63% | 19,883 -8.78% | 1,963 3.37% | 7,399 -9.81% | 6,194 3.04% |
| Cash from Operating Activity | 588.8 218.84% | 14,072 15.96% | 1,653 31.09% | 2,585 -20.85% | 5,005 21.07% |
| Cash from Investment Activity | -489.52 -115.31% | -5,306 -668.76% | -804 -198.88% | -540.05 -221.65% | -3,691 -23.53% |
| Cash from Financing Activity | -95.41 96.42% | -7,906 -17.82% | -799 0% | -2,298 17.34% | -1,293 -7.75% |
| Net Cash Flow | 3.49 -90.1% | 983.12 -78.91% | 50 -74.09% | -261.66 -180.11% | 30.31 161.87% |
RatiosAnnual data as on 13 Dec 2025. | |||||
| PB | 1.77 | 5.77 | 10.22 | 14.42 | 3.73 |
| PE | 50.29 | 39.18 | 77.70 | 65.50 | 23.32 |
| ROE (%) | 6.78 | 16.16 | 15.35 | 26.46 | 18.28 |
| Dividend Yield (%) | 0.13 | 0.90 | 0.47 | 0.87 | 1.05 |
| ROCE (%) | 9.76 | 20.86 | 20.45 | 27.55 | 23.64 |
